E-LIB Suche - Ergebnisse für: Pons-Estel, G.

1

Factors predictive of serious infections over time in syste..:

Pimentel-Quiroz, V R ; Ugarte-Gil, M F ; Harvey, GB...
Lupus. 28 (2019) 9 - p. 1101-1110 , 2019

Link: https://doi.org/10.1177/..

2

Management of non-renal non-neurologic persistent lupus act..:

Scolnik, M ; Scaglioni, V ; Pons-Estel, G J.
Lupus. 28 (2019) 9 - p. 1167-1173 , 2019

Link: https://doi.org/10.1177/..

3

Sixth report of adverse events with biological treatments i..:

Gómez, G. ; Pons-Estel, G. ; Citera, G....
Revista Argentina de Reumatología. , 2019

Link: https://doi.org/10.47196..

4

Remission and low disease activity state (LDAS) are protect..:

Alarcón, G.S. ; Ugarte-Gil, M.F. ; Pons-Estel, G....
Lupus. 28 (2019) 3 - p. 423-426 , 2019

Link: https://doi.org/10.1177/..

5

A 12-year retrospective review of bullous systemic lupus er..:

Pons-Estel, G J ; Quintana, R ; Alarcón, G S...
Lupus. 27 (2018) 10 - p. 1753-1754 , 2018

Link: https://doi.org/10.1177/..

6

Early discoid lupus erythematosus protects against renal di..:

Pons-Estel, G J ; Aspey, L D ; Bao, G...
Lupus. 26 (2016) 1 - p. 73-83 , 2016

Link: https://doi.org/10.1177/..

7

The association between antiphospholipid antibodies and pre..:

Chighizola, C B ; Andreoli, L ; de Jesus, G Ramires...
Lupus. 24 (2015) 9 - p. 980-984 , 2015

Link: https://doi.org/10.1177/..

8

Lupus in Latin-American patients: lessons from the GLADEL c..:

Pons-Estel, G J ; Catoggio, L J ; Cardiel, M H...
Lupus. 24 (2015) 6 - p. 536-545 , 2015

Link: https://doi.org/10.1177/..

9

Nephropathy associated with antiphospholipid antibodies in ..:

Silvariño, R ; Sant, F ; Espinosa, G...
Lupus. 20 (2011) 7 - p. 721-729 , 2011

Link: https://doi.org/10.1177/..

10

Predictors of cardiovascular damage in patients with system..:

Pons-Estel, G. J. ; Gonzalez, L. A. ; Zhang, J....
Rheumatology. 48 (2009) 7 - p. 817-822 , 2009

Link: https://doi.org/10.1093/..

11

Renal damage is the most important predictor of mortality w..:

Danila, M. I. ; Pons-Estel, G. J. ; Zhang, J....
Rheumatology. 48 (2008) 5 - p. 542-545 , 2008

Link: https://doi.org/10.1093/..

12

Anti–Neutrophil Extracellular Trap Antibodies in Antiphosph..:

Zuo, Y ; Navaz, S ; Tsodikov, A...
https://discovery.ucl.ac.uk/id/eprint/10171637/1/Anti%20Neutrophil%20Extracellular%20Trap%20Antibodies%20in%20Antiphospholipid%20Antibody%20Positive.pdf. , 2023

Link: https://discovery.ucl.ac..

13

DORIS definition of remission in SLE: final recommendations..:

van Vollenhoven RF ; Bertsias G ; Doria A...
info:eu-repo/semantics/altIdentifier/pmid/34819388. , 2021

Link: https://hdl.handle.net/1..

14

Associations of baseline use of biologic or targeted synthe..:

Sparks J. A ; Wallace Z. S ; Seet A. M...
info:eu-repo/semantics/altIdentifier/pmid/34049860. , 2021

Link: http://hdl.handle.net/10..

15

2021 DORIS definition of remission in SLE: final recommenda..:

Van Vollenhoven, RF ; Bertsias, G ; Doria, A...
https://discovery.ucl.ac.uk/id/eprint/10139506/1/e000538.full.pdf. , 2021

Link: https://discovery.ucl.ac..